Scope and Cost of Services
ECRIN members and observers can benefit from the full range of ECRIN services for multinational trial preparation, protocol evaluation through an independent peer review committee based on clear assessment criteria, and/or operational trial management.
Advice and information are provided free of charge by the ECRIN core team and European correspondents (EuCos) to academic clinical trial projects involving at least two ECRIN member and observer countries.
Trial management services are provided at not-for-profit rates to academic sponsors. In particular, ECRIN charges the non-profit cost of the distributed services carried out by the national scientific partner (in its member / observer countries). This budget is then redistributed to the final service provider (i.e. the national scientific partner).
To find out more on conditions of access and/or submit your project, contact your European correspondent and consult the ECRIN policy “Access to ECRIN Clinical Project Services” and the ECRIN Scientific Board eligibility criteria for access to clinical project services.
Click here to see the list of ECRIN Scientific Board members.
To be eligible for ECRIN support, projects must involve at least two member or observer countries. Projects must be reviewed and approved by ECRIN (Collaboration Committee).
ECRIN can provide support services even if the trial’s coordinating country is not a member or observer, provided that the project involves at least two member and observer countries. In this case, one of ECRIN’s EuCos or the core team is assigned to the trial. However, countries that are not members or observers cannot benefit from support during the period of grant proposal preparation and study design development.
Who to Contact
Additional Information on Cost Policy
ECRIN also offers services to industry sponsors at market rates. These activities do not account for more than 20% of the ECRIN portfolio, as described in its Statutes. In such cases, a separate accounting system is used without VAT exemption.